Premium
SARS‐CoV‐2 antibody responses in solid organ transplant recipients
Author(s) -
Zervou Fainareti N.,
Ali Nicole M.,
Neumann Henry J.,
Madan Rebecca Pellett,
Mehta Sapna A.
Publication year - 2021
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.13728
Subject(s) - medicine , seroconversion , interquartile range , immunosuppression , immunology , antibody , univariate analysis , odds ratio , organ transplantation , immunoglobulin g , transplantation , multivariate analysis
Antibody responses among immunocompromised solid organ transplant recipients (SOT) infected with Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) may be diminished compared to the general population and have not been fully characterized. We conducted a cohort study at our transplant center to investigate the rate of seroconversion for SARS‐CoV‐2 IgG antibodies among SOT recipients who were diagnosed with Coronavirus disease 2019 (COVID‐19) and underwent serum SARS‐CoV‐2 IgG enzyme‐linked immunosorbent assay (ELISA) testing. The 61 patients who were included in the final analysis underwent initial SARS‐CoV‐2 IgG testing at a median of 62 days (Interquartile range 55.0–75.0) from symptom onset. Note that, 51 of 61 patients (83.6%) had positive SARS‐CoV‐2 IgG results, whereas 10 (16.4%) had negative IgG results. Six (60%) out of 10 seronegative patients underwent serial IgG testing and remained seronegative up to 17 weeks post‐diagnosis. Use of belatacept in maintenance immunosuppression was significantly associated with negative IgG antibodies to SARS‐CoV‐2 both in univariate and multivariate analyses (Odds ratio 0.04, p = .01). In conclusion, the majority of organ transplant recipients with COVID‐19 in our study developed SARS‐CoV‐2 antibodies. Further longitudinal studies of the durability and immunologic role of these IgG responses and the factors associated with lack of seroconversion are needed.